NU

Nu-Med Plus IncOOTC NUMD Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

0.004

Micro

Exchange

OOTC - OTC

NUMD Stock Analysis

NU

Uncovered

Nu-Med Plus Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.004

Dividend yield

Shares outstanding

81.349 B

Nu-Med Plus, Inc. is a medical device company. The Company is engaged in developing, manufacturing and marketing various technologies utilizing nitric oxide in the medical device field, primarily through the creation of a nitric oxide generating compound formulation and delivery systems. Its primary focus is on the development of a nitric oxide generating formulation, a hospital bedside nitric oxide delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. It also developed a prototype lightweight Portable NO Delivery System that can be worn by patients outside of the hospital setting for underserved chronic therapies, and for applications within the United States and in developing nations. It is also developing a powder formulation to generate nitric oxide with a one-year shelf life.

View Section: Eyestock Rating